News Focus
News Focus
Followers 7
Posts 737
Boards Moderated 0
Alias Born 08/25/2012

Re: marjac post# 369624

Thursday, 02/10/2022 3:45:35 PM

Thursday, February 10, 2022 3:45:35 PM

Post# of 447434
The ICER report stating Vascepa is a very cost effective drug that will lower health care cost for the public. Badly needs marketing to a Covid distracted medical field.

I'm 100% in favor of generics sticking to their skinny label. Can someone show me 10 competent medical practitioners that would write a Vascepa script without a CV benefit intended? Most obvious abuse of the skinny label I think you can find and it was created by a Judge Du. Does she have any responsibility in reviewing her patent decision and the "unintended" consequences.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News